Xiongwen Tang

Two-level lognormal frailty model and competing risks model with missing cause of failure

Xiongwen Tang, 2012 .

Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.

Qi Li, P. Keegan, Jianxing He, 2022, Cancer cell.

Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

Ying Cheng, P. Keegan, Baolan Li, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G4 Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial

K. Flaherty, Xiongwen Tang, Li Zhou, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis

K. Flaherty, Xiongwen Tang, Li Zhou, 2022, Journal for ImmunoTherapy of Cancer.

A Phase III study of atezolizumab with carboplatin plus etoposide in patients with extensive-stage small cell lung cancer (IMpower133)

G. Giaccone, T. Mok, Xiongwen Tang, 2016 .

Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.

Xiaozhong Chen, Chaosu Hu, Xiongwen Tang, 2023, JAMA.